'MCC' protein interacts with E-cadherin and β-catenin strengthening cell-cell adhesion of HCT116 colon cancer cells.
Benthani, FA
Herrmann, D
Tran, PN
Pangon, L
Lucas, MC
Allam, AH
Currey, N
Al-Sohaily, S
Giry-Laterriere, M
Warusavitarne, J
Timpson, P
Kohonen-Corish, MRJ
- Publisher:
- NATURE PUBLISHING GROUP
- Publication Type:
- Journal Article
- Citation:
- Oncogene, 2018, 37, (5), pp. 663-672
- Issue Date:
- 2018-02-01
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
'MCC'_protein_interacts_with_E.pdf | Published version | 2.43 MB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Benthani, FA | |
dc.contributor.author | Herrmann, D | |
dc.contributor.author | Tran, PN | |
dc.contributor.author | Pangon, L | |
dc.contributor.author | Lucas, MC | |
dc.contributor.author | Allam, AH | |
dc.contributor.author | Currey, N | |
dc.contributor.author | Al-Sohaily, S | |
dc.contributor.author | Giry-Laterriere, M | |
dc.contributor.author | Warusavitarne, J | |
dc.contributor.author | Timpson, P | |
dc.contributor.author | Kohonen-Corish, MRJ | |
dc.date.accessioned | 2022-09-12T23:06:24Z | |
dc.date.available | 2017-08-25 | |
dc.date.available | 2022-09-12T23:06:24Z | |
dc.date.issued | 2018-02-01 | |
dc.identifier.citation | Oncogene, 2018, 37, (5), pp. 663-672 | |
dc.identifier.issn | 0950-9232 | |
dc.identifier.issn | 1476-5594 | |
dc.identifier.uri | http://hdl.handle.net/10453/161767 | |
dc.description.abstract | E-cadherin and β-catenin are key proteins that are essential in the formation of the epithelial cell layer in the colon but their regulatory pathways that are disrupted in cancer metastasis are not completely understood. Mutated in colorectal cancer (MCC) is a tumour suppressor gene that is silenced by promoter methylation in colorectal cancer and particularly in patients with increased lymph node metastasis. Here, we show that MCC methylation is found in 45% of colon and 24% of rectal cancers and is associated with proximal colon, poorly differentiated, circumferential and mucinous tumours as well as increasing T stage and larger tumour size. Knockdown of MCC in HCT116 colon cancer cells caused a reduction in E-cadherin protein level, which is a hallmark of epithelial-mesenchymal transition in cancer, and consequently diminished the E-cadherin/β-catenin complex. MCC knockdown disrupted cell-cell adhesive strength and integrity in the dispase and transepithelial electrical resistance assays, enhanced hepatocyte growth factor-induced cell scatter and increased tumour cell invasiveness in an organotypic assay. The Src/Abl inhibitor dasatinib, a candidate anti-invasive drug, abrogated the invasive properties induced by MCC deficiency. Mechanistically, we establish that MCC interacts with the E-cadherin/β-catenin complex. These data provide a significant advance in the current understanding of cell-cell adhesion in colon cancer cells. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | NATURE PUBLISHING GROUP | |
dc.relation | http://purl.org/au-research/grants/nhmrc/1020406 | |
dc.relation.ispartof | Oncogene | |
dc.relation.isbasedon | 10.1038/onc.2017.362 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 1103 Clinical Sciences, 1112 Oncology and Carcinogenesis | |
dc.subject.classification | Oncology & Carcinogenesis | |
dc.subject.mesh | Antigens, CD | |
dc.subject.mesh | Antineoplastic Agents | |
dc.subject.mesh | Cadherins | |
dc.subject.mesh | Cell Adhesion | |
dc.subject.mesh | Cell Membrane | |
dc.subject.mesh | Cohort Studies | |
dc.subject.mesh | Colon | |
dc.subject.mesh | Colorectal Neoplasms | |
dc.subject.mesh | DNA Methylation | |
dc.subject.mesh | Dasatinib | |
dc.subject.mesh | Epithelial-Mesenchymal Transition | |
dc.subject.mesh | Gene Expression Regulation, Neoplastic | |
dc.subject.mesh | Gene Knockdown Techniques | |
dc.subject.mesh | HCT116 Cells | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Lymphatic Metastasis | |
dc.subject.mesh | Neoplasm Invasiveness | |
dc.subject.mesh | Neoplasm Staging | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | Promoter Regions, Genetic | |
dc.subject.mesh | Protein Binding | |
dc.subject.mesh | Tumor Suppressor Proteins | |
dc.subject.mesh | beta Catenin | |
dc.subject.mesh | Colon | |
dc.subject.mesh | HCT116 Cells | |
dc.subject.mesh | Cell Membrane | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Colorectal Neoplasms | |
dc.subject.mesh | Neoplasm Invasiveness | |
dc.subject.mesh | Lymphatic Metastasis | |
dc.subject.mesh | Cadherins | |
dc.subject.mesh | Tumor Suppressor Proteins | |
dc.subject.mesh | Antineoplastic Agents | |
dc.subject.mesh | Antigens, CD | |
dc.subject.mesh | Neoplasm Staging | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | Cohort Studies | |
dc.subject.mesh | Cell Adhesion | |
dc.subject.mesh | DNA Methylation | |
dc.subject.mesh | Gene Expression Regulation, Neoplastic | |
dc.subject.mesh | Protein Binding | |
dc.subject.mesh | beta Catenin | |
dc.subject.mesh | Promoter Regions, Genetic | |
dc.subject.mesh | Gene Knockdown Techniques | |
dc.subject.mesh | Epithelial-Mesenchymal Transition | |
dc.subject.mesh | Dasatinib | |
dc.title | 'MCC' protein interacts with E-cadherin and β-catenin strengthening cell-cell adhesion of HCT116 colon cancer cells. | |
dc.type | Journal Article | |
utslib.citation.volume | 37 | |
utslib.location.activity | England | |
utslib.for | 1103 Clinical Sciences | |
utslib.for | 1112 Oncology and Carcinogenesis | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science | |
utslib.copyright.status | closed_access | * |
dc.date.updated | 2022-09-12T23:06:23Z | |
pubs.issue | 5 | |
pubs.publication-status | Published | |
pubs.volume | 37 | |
utslib.citation.issue | 5 |
Abstract:
E-cadherin and β-catenin are key proteins that are essential in the formation of the epithelial cell layer in the colon but their regulatory pathways that are disrupted in cancer metastasis are not completely understood. Mutated in colorectal cancer (MCC) is a tumour suppressor gene that is silenced by promoter methylation in colorectal cancer and particularly in patients with increased lymph node metastasis. Here, we show that MCC methylation is found in 45% of colon and 24% of rectal cancers and is associated with proximal colon, poorly differentiated, circumferential and mucinous tumours as well as increasing T stage and larger tumour size. Knockdown of MCC in HCT116 colon cancer cells caused a reduction in E-cadherin protein level, which is a hallmark of epithelial-mesenchymal transition in cancer, and consequently diminished the E-cadherin/β-catenin complex. MCC knockdown disrupted cell-cell adhesive strength and integrity in the dispase and transepithelial electrical resistance assays, enhanced hepatocyte growth factor-induced cell scatter and increased tumour cell invasiveness in an organotypic assay. The Src/Abl inhibitor dasatinib, a candidate anti-invasive drug, abrogated the invasive properties induced by MCC deficiency. Mechanistically, we establish that MCC interacts with the E-cadherin/β-catenin complex. These data provide a significant advance in the current understanding of cell-cell adhesion in colon cancer cells.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph